Pre‐treatment by omalizumab allows allergen immunotherapy in children and young adults with severe allergic asthma

E-ISSN： 1399-3038|25|8|829-832

ISSN： 0905-6157

Source： PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol.25, Iss.8, 2014-12, pp. : 829-832

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Omalizumab could be effective in children with severe eosinophilic non‐allergic asthma

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 29, Iss. 1, 2018-02 ,pp. : 90-93

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improvement in quality of life with omalizumab in patients with severe allergic asthma

By Chipps Bradley Buhl Roland Beeh Kai-Michael Fox Howard Thomas Karen Reisner Colin

Current Medical Research and Opinion, Vol. 22, Iss. 11, 2006-11 ,pp. : 2201-2208

Informa Healthcare

Access to resources Recommend Favorite

Omalizumab for Severe Allergic Asthma: 7 Years and Open Questions

Respiration, Vol. 88, Iss. 2, 2014-05 ,pp. : 158-161

Karger

Access to resources Recommend Favorite

Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis

By Busse William W. Massanari Marc Kianifard Farid Geba Gregory P.

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2379-2386

Informa Healthcare

Access to resources Recommend Favorite

Safety and tolerability of omalizumab in children with allergic (IgE-mediated) asthma

By Milgrom Henry Fowler-Taylor Angel Vidaurre Carlos Fernandez Jayawardene Sumedha

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 163-169

Informa Healthcare

Access to resources Recommend Favorite